Labcorp Holdings Inc.
Explore Labcorp Holdings
Core profile pages, annual revenue records, and related research hubs for this company.
Labcorp Holdings Inc.
Explore Labcorp Holdings
Core profile pages, annual revenue records, and related research hubs for this company.
Company History
Founded 1995 in Burlington, North Carolina
Modern Labcorp was formed in 1995 when National Health Laboratories and Roche Biomedical Laboratories combined, creating a national independent laboratory platform with the scale to compete across routine and specialty testing.
James Powell is an American healthcare entrepreneur who founded National Health Laboratories in the 1970s and grew it into one of the largest clinical laboratory companies in the United States through a series of acquisitions of independent local laboratories. National Health Laboratories merged with Roche Biomedical Laboratories in 1995 to form Laboratory Corporation of America Holdings (Labcorp), creating the second-largest independent clinical laboratory company in the US. Powell's strategy of industry consolidation and operational scale became the dominant model for the clinical laboratory services market.
Roche Holdings, the Swiss pharmaceutical and diagnostics conglomerate, contributed Roche Biomedical Laboratories to the 1995 merger that created Labcorp. As one of the world's largest healthcare companies, Roche brought scientific expertise, diagnostic technology, and international relationships to the merged entity. Roche maintained a significant equity stake in Labcorp post-merger and the relationship has continued to provide Labcorp with access to advanced testing technologies and companion diagnostic development partnerships.
National Health Laboratories and Roche Biomedical Laboratories combine to form Laboratory Corporation of America Holdings.
Labcorp expands deeply into drug development and biopharma laboratory services.
Labcorp spins off Fortrea, sharpening its focus on diagnostics and laboratory services.
Labcorp reports $13.9517 billion in revenue and nearly 71,000 employees serving clients in about 100 countries.
Labcorp acquired Covance to create an integrated healthcare diagnostics company spanning drug development and patient diagnostics. Covance was a leading contract research organization providing central laboratory services, toxicology, and clinical trial management. The acquisition was expected to generate annual cost synergies exceeding $100 million within three years.
Labcorp acquired Sequenom to strengthen its position in non-invasive prenatal testing (NIPT) and women's health genetic screening. Sequenom was a molecular diagnostics company with proprietary technology for prenatal genetic testing.
Labcorp acquired PGDx to add liquid biopsy and tissue-based genomic profiling capabilities for oncology. PGDx specialized in precision oncology diagnostics, including comprehensive genomic profiling for solid tumors.
Labcorp acquired select assets of Invitae, a genetic testing company, to advance its strategy to launch and scale specialty testing in oncology and rare diseases. The acquisition added genetic counseling capabilities, variant interpretation expertise, and a broad genetic test menu.
Labcorp acquired select assets of BioReference Health's diagnostic business to increase access to Labcorp's clinical laboratory services, with a focus on clinical diagnostics and reproductive and women's health.
Labcorp was founded in 1995 by Formed through merger of Roche Biomedical Laboratories and National Health Laboratories; key historical leaders include James Powell (National Health Laboratories) and David King (post-merger CEO).
Early product focus, operating discipline, and customer relationships shaped Labcorp's expansion.
Labcorp's latest annual results and leadership updates mark the current chapter of the company.
This profile summarizes the founding, expansion, leadership, and modern strategy eras.